Narasin (NAR) - Medicating Ingredient Brochure

This page is part of the Guidance Document Repository (GDR).

Looking for related documents?
Search for related documents in the Guidance Document Repository

Status: Over the counter

Revised September 2021

Table of approved species and claims
Approved livestock species	Approved claim(s) (abbreviated) ^{Table Note 1}	Withdrawal time	Name of approved brand(s)
Broiler chickens	Aid in the prevention of coccidiosis	0 days	Monteban 100 Premix
Growing-finishing swine	Increased rate of weight gain and improved feed efficiency	0 days	Monteban 100 Premix

Table Note

Table Note 1

In order to be compliant with the Feeds Regulations, the complete claim must appear on the medicated feed label.

Return to table note 1 referrer

Broiler chickens

Table of approved claims and brands
Approved claims	Name of approved brand(s)	Drug concentration in DIN product
Claim 1	Monteban 100 Premix	Narasin at 100 g/kg

Approved for use in meal or pellet feed

Claim 1

As an aid in the prevention of coccidiosis in broiler chickens caused by Eimeria acervulinam, Eimeria brunetti, Eimeria maxima, Eimeria necatrix, Eimeria tenella, and Eimeria mitis in broiler chickens.

Level of medicating ingredient in a complete feed

70 mg/kg (0.0070%) of narasin in the complete feed.

Directions

Feed this medicated feed continuously as the sole ration.

Additional information (not to appear on feed labels)

For feed manufacturers

Thoroughly mix the narasin premix with a portion of the feed ingredients prior to the incorporation in the complete feed being prepared.

Warning

Do not feed to laying chickens.
When mixing and handling, use protective clothing, impervious gloves, and a dust mask. If accidental eye contact occurs, immediately rinse thoroughly with water. Operators should wash thoroughly with soap and water after handling (Required on premix and supplement labels only).
No withdrawal period is required when this medicated feed is fed at the recommended level of 70 mg/kg (0.007%) of narasin in the complete feed.
Keep out of reach of children. (Required on premix and supplement labels only)

Caution

Do not allow canines, horses or other equines access to formulations containing narasin. Ingestion of narasin by these species has been fatal.
Poultry consuming narasin should not be treated with products containing tiamulin. Severe growth depression may occur.
Do not feed to turkeys.
In the absence of coccidiosis, feeds containing in excess of 70 mg/kg narasin may reduce the performance of growing broiler chickens.
Do not use this medicated feed for the treatment of outbreaks of coccidiosis.
Not to be used in feeds containing pellet binding agents with the exception of Basfin (0.03%) Lignosol (4%) and Bentonite (2%). (Required on premix and supplement labels only)

Accepted Compatibilities

Narasin is compatible with the following drugs. In cases where there are differences in withdrawal time for the compatible medicating ingredients, the longer withdrawal time is the one that must be used, and is the only one that is to appear on the label of the finished feed. For further details, refer to the MIB as indicated.

Narasin (broiler chickens)
Name of medicating ingredient	MIB code	Name of approved brand(s)	Applicable claims
Avilamycin	AVI	Surmax Premix	All claims
Bacitracin (as bacitracin methylenedisalicylate)	BACN-M	BMD 110 G Bacitracin MD	All claims
Tylosin	TYL	Pharmasin 40 Tylosin Phosphate Premix Pharmasin 100 Tylosin Phosphate Premix Tylan 40 Tylosin Phosphate Premix Tylan 100 Tylosin Phosphate Premix Tylosoin 40 Tylosin Phosphate Premix Tylosin 100 Tylosin Premix	All claims

Growing-finishing swine

Table of approved claims and brands
Approved claims	Name of approved brand(s)	Drug concentration in DIN product
Claim 1	Monteban 100 Premix	Narasin at 100 g/kg